Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)

Name: Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
Published: 2019
License: Public Domain

Vifor Pharma, Inc. · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

chronic-kidney-disease heart-failure hypertension potassium

hyperkalemia, treatment of hyperkalemia, chronic kidney disease, hypertension, potassium, spironolactone, heart failure, renin angiotensin-aldosterone system inhibitor (raasi), raasi, high potassium, eplerenone, reduced ejection fraction

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 875264
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.